State Bank of India acquisition brings significant advantages to investors and stakeholders in CareEdge Global IFSC.
Anti-cancer drug prices are a concern; learn about the recent cautions from KPRDO and their impact on pharmacies.
Anti-Cancer Drug Price Controls are set to take effect on November 9, impacting 137 drugs and 1,031 formulations.
EU-GMP approval has significant implications for pharmaceutical companies aiming for quality standards.
Orexin FDA approval marks a significant milestone in pharmaceutical advancements. Discover its implications for patients and healthcare.
Sun Pharma shares have seen a significant rise following USFDA approval for ILUMYA.
Ashika Global Securities acquisition news highlights a significant 26% stake in Resurgent India Rating, showcasing growth potential.
Medicine overcharging claims are raising concerns about price controls in India.
Cancer drug prices are set to fall by up to 70% thanks to NPPA’s new trade margin caps.
Ethiopian approvals for pharmaceuticals are crucial for Pakistan’s export growth. Discover how faster approvals can benefit both nations.
